To understand the impact of genomic structural variation on human disease, GrandOmics, a leading domestic sequencing company, announced a large-scale sequencing project called dbSV-100K.The project aims to use high-throughput nanopore sequen... Read More >

Recently, Kehua Biotech released the first quarter report of 2019. During the reporting period, the company realized the main business income of 506 million yuan, an increase of 11.8%; the net profit attributable to shareholders of listed co... Read More >

Australian diagnostics firm Genetic Technologies said recently that it has signed a memorandum of understanding to commercialize its range of polygenic risk tests in the US with the Translational Genomics Research Institute. Under the terms... Read More >

Thermo Fisher Scientific and NX Prenatal said recently that they have partnered on the development of mass spectrometry-based proteomics assays for adverse pregnancy outcomes. Under the terms of the deal, the companies will combine NXs NeXos... Read More >

UK molecular diagnostics firm Yourgene Health said recently that it has agreed to acquire Elucigene for 9.2 million ($12.0 million) in cash and stock in a bid to bolster its presence in the noninvasive prenatal testing (NIPT) market. To fund... Read More >

Natera announced recently that it has prices its $100 million common stock offering. The San Carlos, California-based molecular diagnostics firm is offering 5,263,158 shares of common stock at $19 per share. Gross proceeds from the offering... Read More >

Danaher reported recetly a 4 percent year over year increase in total revenues paced by a 10 percent jump in the Life Sciences business. For the three months ending March 29, total revenues were $4.88 billion compared to $4.70 billion in the... Read More >

Expedeon today posted a 68 percent increase in revenues for full-year 2018 as the company benefited from sales generated by recent acquisitions. For the 12-month period ended Dec. 31, Expedeons revenues climbed to 13.1 million ($14.6 million... Read More >

PerkinElmer reported after the close of the market on Thursday that total revenues for the first quarter of 2019 inched up a fraction of 1 percent year over year while revenues from its Diagnostics division grew 5 percent. For the three mont... Read More >

iCubate said today that it has formed a joint venture with Wondfo Biotech to commercialize infectious disease molecular diagnostics in China. The joint venture called Wondfo-iCubate Biotech will develop assays using iCubates amplicon-rescued... Read More >